Penetration of ceftazidime into heart valves and subcutaneous and muscle tissue of patients undergoing open-heart surgery. 1987

U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner

Patients undergoing open-heart surgery were given an intravenous bolus injection of 2 g of ceftazidime as a single dose over a period of 5 min. Within 12 h, ceftazidime concentrations in serum declined from 55.8 to 3.9 mg/liter. Subcutaneous tissue concentrations of the drug decreased from 21.0 to 2.7 micrograms/g, and muscle concentrations decreased from 34.5 to 2.5 micrograms/g. Ceftazidime concentrations in cardiac valvular tissue were even higher than those in muscle or fat, declining from 37.4 to 6.3 micrograms/g within 10 h.

UI MeSH Term Description Entries
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D005260 Female Females
D006348 Cardiac Surgical Procedures Surgery performed on the heart. Cardiac Surgical Procedure,Heart Surgical Procedure,Heart Surgical Procedures,Procedure, Cardiac Surgical,Procedure, Heart Surgical,Procedures, Cardiac Surgical,Procedures, Heart Surgical,Surgical Procedure, Cardiac,Surgical Procedure, Heart,Surgical Procedures, Cardiac,Surgical Procedures, Heart
D006351 Heart Valves Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles. Cardiac Valves,Cardiac Valve,Heart Valve,Valve, Cardiac,Valve, Heart,Valves, Cardiac,Valves, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
November 1979, The Journal of antimicrobial chemotherapy,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
October 1984, The Journal of antimicrobial chemotherapy,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
June 1982, The Journal of antimicrobial chemotherapy,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
January 1981, The Journal of cardiovascular surgery,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
November 1997, Antimicrobial agents and chemotherapy,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
May 1983, Clinical cardiology,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
January 1985, Infection,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
January 1985, Scandinavian journal of thoracic and cardiovascular surgery,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
August 1980, The Journal of infectious diseases,
U Frank, and I Kappstein, and E Schmidt-Eisenlohr, and V Schlosser, and G Spillner, and M Schindler, and F D Daschner
July 1983, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!